Cargando…
New Treatments in Spinal Muscular Atrophy: Positive Results and New Challenges
Spinal muscular atrophy (SMA) is one of the most common autosomal recessive diseases with progressive weakness of skeletal and respiratory muscles, leading to significant disability. The disorder is caused by mutations in the survival motor neuron 1 (SMN1) gene and a consequent decrease in the SMN p...
Autores principales: | Messina, Sonia, Sframeli, Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408870/ https://www.ncbi.nlm.nih.gov/pubmed/32668756 http://dx.doi.org/10.3390/jcm9072222 |
Ejemplares similares
-
Advances in Treatment of Spinal Muscular Atrophy – New Phenotypes, New Challenges, New Implications for Care
por: Schorling, David C., et al.
Publicado: (2020) -
Diagnostic journey in Spinal Muscular Atrophy: Is it still an odyssey?
por: Pera, Maria Carmela, et al.
Publicado: (2020) -
Emerging therapies and challenges in spinal muscular atrophy
por: Farrar, Michelle A., et al.
Publicado: (2017) -
Molecular Pathogenesis and New Therapeutic Dimensions for Spinal Muscular Atrophy
por: López-Cortés, Andrés, et al.
Publicado: (2022) -
Alternative Splicing Role in New Therapies of Spinal Muscular Atrophy
por: Lejman, Jan, et al.
Publicado: (2021)